Described herein are genes whose expression are up-regulated or
down-regulated in prostate cancer. Also described are such genes whose
expression is further up-regulated or down-regulated in drug-resistant
prostate cancer cells. Related methods and compositions that can be used
for diagnosis and treatment of prostate cancer are disclosed. Also
described herein are methods that can be used to identify modulators of
prostate cancer.